Illumina Supports Leading German Hospital to Accelerate Genetic Disease Diagnosis in Critically Ill Children

Corporate Breaking News

Home : Illumina Supports Leading German Hospital to Accelerate Genetic Disease Diagnosis in Critically Ill Children

Apr 25 2022	Illumina Supports Leading German Hospital to Accelerate Genetic Disease Diagnosis in Critically Ill Children
Hannover Medical School study will evaluate the use of whole-genome sequencing to show positive impact of earlier diagnosis and treatment for children with suspected genetic disorders SAN DIEGO, April 25, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA...


Source:https://www.prnewswire.com:443/news-releases/illumina-supports-leading-german-hospital-to-accelerate-genetic-disease-diagnosis-in-critically-ill-children-301530036.html

Related News
» SDRL: New Contract in Angola for Seadrill Joint Venture » - Toward New Future - Fukushima's Challenges 2022: Fukushima Prefecture Releases Video of "Fukushima Now," 11 Years after Great East Japan Earthquake